申请人:Graupe Michael
公开号:US20070054864A1
公开(公告)日:2007-03-08
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及抗病毒剂化合物。具体而言,本发明的化合物抑制HCV的复制,因此可用于治疗丙型肝炎感染。本发明还涉及包含这些化合物的制药组合物以及制备它们的过程。